Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | NHS England |
| Main Category: | — |
| Procurement Method: | Direct award |
| Method Rationale: | PA23 Sch.5 Single supplier - technical reasons |
| Tender Status: | Closed |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 10 June 2026 |
| Application Deadline: | — |
All 4 notices for this procurement, oldest first.
Blood Group Genotyping for Sickle Cell and Thalassaemia
Blood Group Genotyping for Sickle Cell and Thalassaemia
Blood Group Genotyping for Sickle Cell and Thalassaemia
Blood Group Genotyping for Sickle Cell and Thalassaemia
🤝 Need a consortium or subcontracting partner?
SMEs & Primes team up to win opportunities like this. Find partners on the board.
Awarded to
| Award status: | Active |
Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping. Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to commencing 25 June 2025 until 31 March 2026.
Published contracts in the last 12 months
2,046
total contracts
£179666.3m
total value
£251,986,446
average contract size
Typical categories
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Procurement ID (OCID): |
| ocds-h6vhtk-05f01d |
| Notice Reference: | 054590-2026 |